Navigation Links
Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
Date:2/22/2010

99 RESEARCH AND DEVELOPMENT EXPENSE 1,106,385 1,098,525 2,205,960 2,196,450 SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 5,259,213 13,282,421 9,601,019 26,634,396 INCOME FROM OPERATIONS 7,147,295 11,425,697 19,829,569 18,772,853 OTHER (INCOME) EXPENSE: Change in fair value of derivative liabilities (6,687,085) -- (1,865,992) -- Other income - related parties (80,668) (92,774) (161,304) (236,724) Non-operating (income) expense, net 366,685 204,001 214,271 1,193,592 Interest expense, net 6,162,640 1,549,331 8,919,818 2,902,125 Loss from discontinued operations 87,561 1,545,607 164,769 1,590,823 Total other (income) expense, net (150,867) 3,206,165 7,271,562 5,449,816 INCOME BEFORE PROVISION FOR INCOME TAXES 7,298,162 8,219,532 12,558,007 13,323,037 PROVISION FOR INCOME TAXES 1,970,021 2,820,346 5,078,191 4,790,367 NET INCOME $5,328,141 $5,399,186 $7,479,816 $8,532,670 OTHER COMPREHENSIVE INCOME: Unrealized holding gain (loss) 32,827 (384,650) 56,371 (1,947,617) Foreign currency translation adjustment 44,704 248,823 196,884 579,464 COMPREHENSIVE INCOME $5,405,672 $5,263,359 $7,733,071 $7,164,517 BASIC WEIGHTED AVERAGE NUMBER OF SHARES 10,983,405 9,771,883 10,744,648 9,770,615 BASIC EARNINGS PER SHARE $0.49 $0.55 $0.70 $0.87 DILUTED WEIGHTED AVERAGE NUMBER OF SHARES 15,065,301 14,148,317 14,829,605 1
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
2. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
3. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
5. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Market Snapshot: Transcatheter Heart Valve 2007 to ... France , Italy , UK, Spain ... 2007 to 2020 - Europe ( Germany ... Spain )" provides quantitative analysis of the transcatheter heart valves market ... revenue and volume over the 2007–2020 period and key company share data by ...
(Date:9/23/2014)... , Sept. 23, 2014  SI-BONE, Inc., a ... iFuse Implant System, ® a minimally invasive surgical ... joint, today announced that the U.S. Patent and Trademark ... systems and methods for the fixation and fusion of ... fenestrated implant with a tapered distal end that may be placed from ...
(Date:9/23/2014)... 23, 2014  Global Discovery Biosciences, a laboratory dedicated ... the biggest healthcare challenges, announces their collaboration with IPMD, ... test for the early detection of lung cancer. ... death. Typically, the symptoms and subsequent diagnosis of lung ... the chance of a cure has already passed. Early ...
Breaking Medicine Technology:Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Global Discovery Biosciences Announces Collaboration with IPMD, Inc. to Develop Innovative Aptamer-Based Blood Test for the Early Detection of Lung Cancer 2
... Feb. 7, 2011 ConvaTec, a world-leading developer and ... care, today announced the appointment of several executives to ... Pionati has been appointed President, Intercontinental in a newly ... and Canada. These markets continue to be a strategic ...
... Corp. (Nasdaq: BSTC ; the "Company" or ... products, today announced that its Board of Directors has ... 14, 2002 and previously amended June 19, 2003 (the ... for determining "Acquiring Person" status under the Rights Agreement ...
Cached Medicine Technology:ConvaTec Announces New Appointments to Leadership Team 2
(Date:9/23/2014)... The inaugural single day event in Japan will ... Gardens in Tokyo. Clinical data scientists will meet and discuss ... second single day event in China will be ... clinical data scientists attending this event will discuss topics around ... display data collected in clinical studies and beyond. , ...
(Date:9/23/2014)... COLUMBIA, Mo. Infants, vocalizations throughout the first ... crying and cooing to forming syllables and first ... the amount of vocalizations may differ between hearing ... shows that infant vocalizations are primarily motivated by ... infants with profound hearing loss who received cochlear ...
(Date:9/23/2014)... of published studies found that FDG-PET technology is ... disease in regions where infections like histoplasmosis or ... suspicious for cancer could lead to unnecessary tests ... and mortality. , Histoplasmosis and other fungal ... concentrated in bird droppings and are found in ...
(Date:9/23/2014)... World of Home Fitness is committed ... recently, the gym has been raising money to support ... the year, World of Home Fitness has participated in ... Over the summer, World of Home Fitness raised more ... Fitness program, participants helped feed seniors "one rep at ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:World of Home Fitness Supports Meals on Wheels 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2
... for, immunization against diphtheria, tetanus, pertussis, polio and Haemophilus ... ... LYON, France, June 23 Sanofi,Pasteur, the vaccines division of ... Administration (FDA) has licensed Pentacel(R),Diphtheria and Tetanus Toxoids and Acellular ...
... of persistent, recent-onset symptoms linked to ovarian cancer ... quickly and abdominal bloating when combined with the ... ovarian cancer by 20 percent, according to new findings ... online today in CANCER . , Research has ...
... Delivery Unit at The Children,s,Hospital of Philadelphia, the ... birth defects, PHILADELPHIA, June 22 Hundreds ... Hospital of Philadelphia for,the 12th Annual Fetal Surgery ... been followed by the Center for Fetal Diagnosis ...
... are struggling with the health fallout caused by a lack ... Most women don,t need a survey to tell them a ... too sluggish to make it through the day with vigor. ... moms, empty-nesters or grandmothers, many -- if not most -- ...
... best in those under 80, could ease expected worldwide shortfall ... blood substitute product called HBOC-201 proved safe and effective in ... reports. , In all, 688 patients, ages 18 and ... unit of blood (about one pint) or an equivalent one ...
... India, June 20 The United States,has provided ... the Children to assist people affected by the ... Shortages have emerged in recent months because the ... rapidly growing rat infestations in,crop-growing areas. With funds ...
Cached Medicine News:Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 2Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 3Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 4Health News:U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R) 5Health News:Symptom screening plus a simple blood test improves early detection of ovarian cancer 2Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 2Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 3Health News:So Much to Do, So Little Sleep 2Health News:So Much to Do, So Little Sleep 3Health News:Blood Substitute Found Safe in Large Phase III Trial 2
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. The procedure can be done in the office under topical anesthesia. Complete Set Includes Vacuum Speculum, ...
... Streamline family of temporary sensing and pacing ... standard in temporary pacing leads and improved ... to use and less traumatic to heart ... are designed to provide consistent temporary sensing ...
Carbo-Seal Valsalva AAP is the first valved graft to replicate the natural Sinus of Valsalva, encouraging the natural formation of systolic vortices....
Current annuloplasty rings and bands are designed for symmetric dilatation. The IMR ETlogix ring is the first asymmetric ring designed to treat asymmetric dilatation....
Medicine Products: